Hong Kong SAR

Natixis adds to green team — SocGen picks new Apac CEO — GS India co-CEO retires

A Citi banker was arrested by Hong Kong police this week, as the protests in the city intensified.

Over my many years in Hong Kong, I have seen a lot. I've watched the city go from being a British colony to become part of China. I've seen a real estate boom and luxury shopping replace old local stores. I've seen protests and political turmoil. But all that has little prepared me for what has happened here this week.

Alibaba Group Holding has kicked off its up to $13.4bn Hong Kong IPO, set to be the largest listing on the bourse for nearly a decade. Bankers are confident the deal will be a success, but they are navigating challenging times in the city’s stock market, which plunged this week as violence during protests escalated. Jonathan Breen reports.

Asian debt bankers were forced to react to a tumultuous week of protests in Hong Kong, cutting short the bookbuilding window for new deals. But although bankers had to change tactics, the market largely endured the turmoil. Addison Gong reports.

China's Huali University Group launched bookbuilding on Wednesday for its Hong Kong IPO, targeting proceeds of up to HK$978m ($124.9m).

Investors looked beyond Nanyang Commercial Bank's Hong Kong home to its Chinese parent this week, allowing the borrower to close a $700m Basel III-compliant tier two subordinated deal, despite the protests happening in the city.

China Merchants Commercial Real Estate Investment Trust has kicked off a pre-deal investor roadshow for its Hong Kong SAR listing. It is set to break a six-year drought of Reit IPOs on the bourse.

Gaëlle Olivier is set to take over as the chief executive officer for Société Générale Asia Pacific in January next year, succeeding Hikaru Ogata who is leaving the bank.

Alibaba Group Holdings got the greenlight from Hong Kong's stock exchange for a listing that could be worth as much as $15bn. The deal looks set to receive strong anchor demand from Chinese investors.

Xiaofei Guo has joined Natixis to support the bank’s green and sustainable deal origination and solutions sales in Asia Pacific.

Pharmaron Beijing Co, a pharmaceutical research and development service platform, has launched its Hong Kong SAR flotation, aiming to raise up to HK$4.6bn ($587.8m), said a source familiar with the matter.